Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WIPI1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | VHL | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TCEANC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NUP160 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | TARDBP | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | DAXX | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RCOR2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RP11-196G11.1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |